v3.6.0.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
REVENUES:    
Product revenue $ 10,518,203 $ 7,050,283
License and other revenue 142,834 127,350
Total Revenues 10,661,037 7,177,633
OPERATING EXPENSES:    
Cost of product revenue 6,360,761 4,311,461
Research and development 7,688,238 7,015,946
Plasma centers 5,447,691 4,618,065
General and administrative 8,494,742 6,745,968
TOTAL OPERATING EXPENSES 27,991,432 22,691,440
LOSS FROM OPERATIONS (17,330,395) (15,513,807)
OTHER INCOME (EXPENSE):    
Interest income 50,317 37,830
Interest expense (2,239,569) (1,842,716)
Other income 4,496 0
Change in fair value of stock warrants 0 67,860
Loss on extinguishment of debt 0 (719,097)
OTHER EXPENSE, NET (2,184,756) (2,456,123)
NET LOSS $ (19,515,151) $ (17,969,930)
NET LOSS PER COMMON SHARE, Basic and Diluted $ (1.61) $ (1.73)
WEIGHTED AVERAGE SHARES OUTSTANDING, Basic and Diluted 12,153,407 10,412,305

Source